Active Ingredient(s):Abacavir + Lamivudine, 3TC + Zidovudine, ZDV FDA Approved: * November 14, 2000 Pharm Company: *GLAXOSMITHKLINE Category:HIV / AIDS
Abacavir/lamivudine/zidovudine, sold under the brand name Trizivir, is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS. It contains three reverse transcriptase inhibitors patented by GlaxoSmithKline and marketed by a joint venture with Pfizer, ViiV Healthcare:
abacavir sulfate (ABC)
zidovudine (AZT or ZDV)
It is indicated in the treatment of AIDS/HIV-1.[2&...
* May have multiple approval dates, manufacturers, or labelers.